Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection

The waning efficacy of SARS-CoV-2 vaccines combined with the continued emergence of variants resistant to vaccine-induced immunity has reignited debate over the need for booster vaccines. To address this, we examined the neutralizing antibody (nAb) response against four major SARS-CoV-2 variants—D61...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, John P., Zeng, Cong, Carlin, Claire, Lozanski, Gerard, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669844/
https://www.ncbi.nlm.nih.gov/pubmed/34909777
http://dx.doi.org/10.1101/2021.12.06.471455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669844/
https://www.ncbi.nlm.nih.gov/pubmed/34909777
http://dx.doi.org/10.1101/2021.12.06.471455

Ejemplares similares